REGN vs TUSK · P/E 14, rev $4.29B vs rev $48.1M
Regeneron Pharmaceuticals Inc (REGN) versus Mammoth Energy Services Inc (TUSK) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Mammoth Energy Services Inc (TUSK) is a conglomerates company listed on NASDAQ.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TUSK revenue for 2026-06-30 was $48.1M. Net income was $4.4M. TUSK currently screens at market cap $150.3M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TUSK currently screens at market cap $150.3M.
Not investment advice. Open the REGN and TUSK stock pages for the full models.
Not investment advice.